{"title":"Noninvasive Terahertz Therapy Promoted Bone Regeneration via Localized Angiogenesis in a Pre-Clinical Tibial Defect Model.","authors":"Li Liu, Shaohui Geng, Yijin Jiang, Jingyuan Fu, Zixuan Shu, Hongxu Liu, Wenrui Jia, Guangrui Huang","doi":"10.1177/15578550251363058","DOIUrl":null,"url":null,"abstract":"<p><p><b><i>Objective:</i></b> Bone defects present a significant clinical challenge, often requiring surgical intervention due to delayed healing. Terahertz (THz) radiation, a noninvasive physical energy-based therapy, has shown potential in promoting bone regeneration through biomolecular interactions. This study aims to evaluate the therapeutic efficacy of THz irradiation in enhancing bone repair using a pre-clinical rat tibial fracture defect model. <b><i>Methods:</i></b> A standardized tibial bone defect model was created in rats, with daily THz irradiation (0.1 THz, 20 min/session) administered continuously for 28 days. Micro-computed tomography (CT) evaluations were performed weekly throughout the study period, while histological assessments (hematoxylin and eosin [HE] and Masson staining), vascular endothelial growth factor (VEGF) immunohistochemistry, and serum biomarker analyses were exclusively conducted at the 28-days endpoint. Micro-CT imaging, histopathological staining, and tyramide signal amplification analyses were conducted to assess bone volume fraction, collagen deposition, and angiogenesis. Blood biochemical markers were also evaluated to determine systemic metabolic effects. <b><i>Results:</i></b> By week 4, the THz-treated group demonstrated a higher new bone formation compared with control group. Micro-CT analysis revealed significantly improved cortical continuity and bone volume fraction at weeks 3 and 4 (<i>p</i> < 0.05). HE and Masson staining showed enhanced collagen alignment and trabecular organization. The IF test indicated increased VEGFA expression in local new bone (<i>p</i> < 0.01), suggesting augmented angiogenesis. No significant changes were observed in serum <i>biochemistry</i> markers, indicating localized rather than systemic effects. <b><i>Conclusions:</i></b> THz radiation effectively accelerates bone defect healing by enhancing osteoblast activity and vascularization without systemic metabolic alterations. These findings highlight the potential of THz therapy as a novel, noninvasive approach for bone regeneration, warranting further research for clinical translation.</p>","PeriodicalId":94169,"journal":{"name":"Photobiomodulation, photomedicine, and laser surgery","volume":" ","pages":"417-424"},"PeriodicalIF":1.8000,"publicationDate":"2025-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Photobiomodulation, photomedicine, and laser surgery","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1177/15578550251363058","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2025/8/20 0:00:00","PubModel":"Epub","JCR":"Q2","JCRName":"SURGERY","Score":null,"Total":0}
引用次数: 0
Abstract
Objective: Bone defects present a significant clinical challenge, often requiring surgical intervention due to delayed healing. Terahertz (THz) radiation, a noninvasive physical energy-based therapy, has shown potential in promoting bone regeneration through biomolecular interactions. This study aims to evaluate the therapeutic efficacy of THz irradiation in enhancing bone repair using a pre-clinical rat tibial fracture defect model. Methods: A standardized tibial bone defect model was created in rats, with daily THz irradiation (0.1 THz, 20 min/session) administered continuously for 28 days. Micro-computed tomography (CT) evaluations were performed weekly throughout the study period, while histological assessments (hematoxylin and eosin [HE] and Masson staining), vascular endothelial growth factor (VEGF) immunohistochemistry, and serum biomarker analyses were exclusively conducted at the 28-days endpoint. Micro-CT imaging, histopathological staining, and tyramide signal amplification analyses were conducted to assess bone volume fraction, collagen deposition, and angiogenesis. Blood biochemical markers were also evaluated to determine systemic metabolic effects. Results: By week 4, the THz-treated group demonstrated a higher new bone formation compared with control group. Micro-CT analysis revealed significantly improved cortical continuity and bone volume fraction at weeks 3 and 4 (p < 0.05). HE and Masson staining showed enhanced collagen alignment and trabecular organization. The IF test indicated increased VEGFA expression in local new bone (p < 0.01), suggesting augmented angiogenesis. No significant changes were observed in serum biochemistry markers, indicating localized rather than systemic effects. Conclusions: THz radiation effectively accelerates bone defect healing by enhancing osteoblast activity and vascularization without systemic metabolic alterations. These findings highlight the potential of THz therapy as a novel, noninvasive approach for bone regeneration, warranting further research for clinical translation.